Stock LAB STANDARD BIOTOOLS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Standard BioTools Inc.

Equities

LAB

US34385P1084

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-19 pm EDT 		5-day change 1st Jan Change
2.52 USD -0.79% Intraday chart for Standard BioTools Inc. -9.68% +14.03%
Apr. 16 TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target MT
Apr. 08 Standard BioTools Inc. Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue Imaging CI

Evolution of the average Target Price on Standard BioTools Inc.

Price target over the last 5 years

History of analyst recommendation changes

45f4a2b.5u7wSB6YbNDycutsPKXJMmFEnAt-IkZNBlUPQp-5z14.hZ63IFzLWYKKMJgCa5eCbSJwqmoxV340bBZ3J-f6thLTqZIAd_kF4bdHrg~7494df56144e2ccf97e664b11447ee7d

Analyst Recommendations on Standard BioTools Inc.

TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target MT
Jefferies Initiates Coverage on Standard BioTools With Buy Rating, $3.25 Price Target MT
KeyBanc Initiates Standard BioTools at Overweight With $4 Price Target, Sees 'Attractively Valued Way to Invest' in Life Sciences Technology MT
BTIG Adjusts Fluidigm's Price Target to $10 From $12, Reiterates Buy Rating MT
FLUIDIGM : UBS Adjusts Fluidigm's Price Target to $9 From $10, Reiterates Buy Rating MT
FLUIDIGM : UBS Adjusts Fluidigm's Price Target to $10 From $15, Citing Lower Revenue Forecasts for COVID Testing Business; Buy Rating Kept MT
FLUIDIGM : Piper Sandler Adjusts Fluidigm's Price Target to $15 from $12, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.52 USD
Average target price
3.583 USD
Spread / Average Target
+42.20%
High Price Target
4 USD
Spread / Highest target
+58.73%
Low Price Target
3.25 USD
Spread / Lowest Target
+28.97%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Standard BioTools Inc.

TD Cowen
Jefferies & Co.
KeyBanc Capital Markets
BTIG
UBS

Ratings for Standard BioTools Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LAB Stock
  4. Consensus Standard BioTools Inc.